Articles

Trading below a 15 forward price-to-earnings, these undervalued pharma stocks offer opportunities in an overbought market. More

These dividend stocks may not have the largest yields, but they are growing their payouts at double-digit rates. More

Although Chinese stocks have long been a staple of the funds tied to Cathie Wood, the notable investor is saying no more. More

EV startup Lucid just received a new investment from DNB Asset Management. Here's why this could signal a turnaround for LCID stock. More

With QuantumScape set to report earnings next week, investors appear to be taking a cautious view with QS stock in today's session. More

Although anticipation runs hot for Airbnb that it will continue delivering the goods, investors should recognize the risks with ABNB stock. More

For investors looking for the top growth stocks to buy now, these three intuitive names should do the trick over the long-term. More

Subscriber Sign in